Marrow stromal cells (MSC) and neonatal calvarial cells have the potential to differentiate and express markers of mature osteoblasts. Furthermore, MSCs can generate multiple differentiated connective tissue phenotypes. These properties and their ability to be expanded ex vivo make them good models for ex vivo gene therapy. In this study we examined the ability of vesicular stomatitis virus (VSV-G) pseudotyped retroviral vectors to transduce osteoprogenitor cells derived from bone marrow and from neonatal calvaria. Retrovectors encoding either ␤-galactosidase or green fluorescent protein (eGFP) were used for transduction of primary murine marrow stromal and primary neonatal calvarial cell cultures. High infection efficiency was demonstrated by fluorescence-activated cell analysis when GFP was used as a marker or by estimating the number of ␤-galactosidase-positive cells. Expression of markers of differentiated bone cells, including Col1a1, bone sialoprotein, and osteocalcin mRNA and alkaline phosphatase activity was not impaired by retroviral transduction. Our data suggest that VSV-G pseudotypes retroviral vectors are suitable for introducing genes into osteoprogenitor cells without affecting osteoprogenitor lineage progression.
INTRODUCTION
Primary murine marrow stromal cell (MSC) and primary neonatal calvarial osteoblast cultures (mCOB) are two models currently used to study differentiation of osteoprogenitor cells (Aubin, 1998; Friedenstein, 1995; Malaval et al., 1994; Owen and Friedenstein, 1988) . Depending on the culture conditions, MSC have the potential to differentiate into cells of several lineages such as osteoblasts, chondrocytes, adipocytes, and myocytes. Compared to MSC that originate from mesoderm, calvarial osteoprogenitors arise from neuroectoderm (Dennis et al., 1999; Malaval et al., 1999; Nefussi et al., 1997) . Calvarial cell culture consists of mixed cell populations; some express markers of differentiated osteoblasts, whereas some represent a population of undifferentiated progenitor cells (Aubin et al., 1982) . In both by 7 days of culture, alkaline phosphatase (ALP)-positive colonies begin to form, while the markers of osteoblast differentiation at the mRNA level develop in the second and third week of culture.
MSC meet the important requirements for somatic gene therapy. They contain osteoprogenitor cells that undergo a number of divisions prior to attaining a differentiated osteoblastic phenotype. Marrow stromal-derived progenitors can be easily obtained from a patient, expanded in vitro, and engineered by a number of methods. Once transplanted into the blood stream, MSC were reported to have the ability to home to the bone (Keating et al., 1982; Nilsson et al., 1999) . Using marrow stromal osteoprogenitor cells as a vehicle for somatic gene therapy, a number of diseases can be targeted, including genetic disorders like osteogenesis imperfecta. Indeed, mouse models of osteogenesis imperfecta (OI) phenotype can be used as convenient models to test the effects of somatic gene therapy protocols (Chipman et al., 1993; Forlino et al., 1999; Pereira et al., 1993) .
In order to engineer osteoprogenitor cells to inhibit defective gene expression or to overexpress different growth factors, various types of gene delivery are used. Viral vector delivery has become a frequently used system to deliver a gene into mammalian cells. A broad spectrum of retroviruses, adenoviruses, adeno-associated viruses, herpes simplex virus, and lentiviral vectors are being used as tools to achieve long-term expression of the DNA of interest in targeted cells (Mulligan, 1993) . Replication-defective retroviral vectors are produced by introduction of a viral genome into a packaging cell line. The packaging cell lines have been stably transfected by plasmids encoding the viral structural genes gag, pol, and env in order to provide all components necessary to produce retroviral vectors. Vesicular stomatitis virus (VSV) pseudotyped retrovectors can yield high titers of stable viral particles capable of gaining entry to various cell types because the G glycoprotein of VSV interacts with the phospholipid of the cell membrane (Burns et al., 1993; Emi et al., 1991; Yee et al., 1994a,b) . Moreover, use of polycations like polybrene and protamine sulphate has been shown to increase transduction efficiency without major toxic effects (Cornetta and Anderson, 1989; Manning et al., 1971) . The major disadvantage of these vectors is the inability to transduce nondividing cells (Roe et al., 1993) .
We used the 293GPG packaging cell line, in which the G protein is under the control of the tetracycline-responsive element (tet off system) (Ory et al., 1996) . The aim of this study was to examine the ability of VSV-G pseudotyped retrovectors to introduce exogenous genes into murine osteoprogenitor cells without using additional antibiotic selection. We also wanted to determine whether transduction of these cells altered their ability to undergo osteogenic differentiation in vitro.
RESULTS

Transduction of primary osteoblast cultures
VSV-G pseudotyped retroviral vectors encoding ␤-galactosidase (␤-gal) (MFG.S.nlsLacZ) (Fig. 1A) or green fluorescent protein (eGFP) (MG1) (Fig. 1B) were used to transduce osteoprogenitor cells. Both vectors contain long terminal repeat promoter and enhancer elements. The eGFP-encoding vector also has a cytomegalovirus (CMV) promoter driving the eGFP marker and the neomycin resistance gene.
Infection efficiency in MSC cultures. Marrow stromal cell colonies arise as a single clonal population of osteoprogenitor cells. In order to target early progenitor cells, infections were done on days 4, 5, and 6 as soon as the cells were viable without the supporting hematopoietic layer. Depending on the titer of the retroviral vector, different levels of transduction efficiency were observed. The vector encoding the GFP transgene had a lower titer (5 ϫ 10 4 -1 ϫ 10 5 ) compared to that of the lacZ-encoding vector (1-5 ϫ 10 6 ) and this difference was reflected in the level of infection, as shown in Figs. 2A , 2B, and 3. Using FACS analysis, we were able to detect transduction of 15 to 20% of MSC (Fig. 2C) . The detection of transduced cells using ␤-galactosidase staining showed a high percentage of ␤-galactosidase-expressing stromal cells at day 10 of culture, as seen on digital images of tissue culture plates (Fig. 3A) , as well as individual colonies (Figs. 3B, 3C ).
Infection efficiency in mCOB cultures. Mouse neonatal calvarial cells were derived from sequential enzymatic digestion of whole neonatal calvariae. They began to grow as single cell colonies and become a monolayer by day 7 of culture. If cultured in differentiation medium (ascorbic acid, ␤-glycerol phosphate), they produce multilayered colonies (nodules) and express bone differentiation markers such as bone sialoprotein and osteocalcin. Using fluorescent microscopy, we detected a large number of GFP-expressing cells (Figs. 4A and 4B) . This observation was confirmed by fluorescence-activated cell analysis. Analysis showed that up to 50% of the cells were transduced by the eGFP encoding retrovector (Fig.  4C) . Staining for ␤-galactosidase also revealed high transduction efficiency in primary neonatal calvarial cells. Ten-day-old culture showed uniform expression over the entire culture well (Fig. 5A ) and phase contrast microscopy images showed that most cells express the transgene (Figs. 5B and 5C).
Effect of infection on differentiation of osteoprogenitor cells
The ability of transduced cells to undergo osteoblast lineage progression was evaluated. In the presence of osteoblast differentiation media that included dexamethasone, ascorbic acid, and ␤-glycerol phosphate, both stromal cell cultures and calvarial cultures showed alkaline phosphatase-positive colonies, type I collagen, bone sialoprotein, and osteocalcin mRNA expression. As the retrovector encoding ␤-galactosidase showed a higher rate of infection both in the MSC and in calvarial cell cultures, cells transduced with this vector were used to test their differentiation potential.
FIG. 1. Retroviral vectors. (A)
The retrovector encoding a nuclear localization signal (nls) for the ␤-galactosidase gene (MFG.S.nlsLacZ). The viral construct contains 5Ј and 3Ј long terminal repeats that include promoter and enhancer sequences and a termination codon sequence. (B) The retrovector encoding green fluorescent protein (eGFP) has a GFP marker driven by a CMV early promoter (MG1). The vector includes a sequence for neomycin resistance that is driven by an SV40 promoter.
Differentiation of MSC cultures. There were no differences in the spatial distribution and in the temporal pattern of alkaline phosphatase expression in control and infected MSC cultures. ␤-Galactosidase-positive colonies were detected in infected cultures but not in the control cultures, and infected colonies had levels of alkaline phosphatase expression similar to those of uninfected wells (Fig. 6A) . Likewise, the expression of osteoblast differentiation markers like type I collagen (Col1a1), bone sialoprotein (BSP), and osteocalcin (OC) was similar in infected and in control cultures (Fig. 6B) .
Differentiation of mCOB cultures. Similar results were observed in mCOB cultures that normally show homogeneous expression of ALP throughout the culture (Fig. 7A ). There was no difference in mineralization between the uninfected and infected cells, as shown on Fig. 6A , whereas numerous ␤-galactosidase-positive cells were observed under and inside the mineralized regions of the calvarial cell cultures (Figs. 7B and 7C ). Strong GFP expression was seen in cells that constitute the mineralized region of a nodule, as well in cells in internodular positions (Figs. 7D and 7E) . Col1a1, BSP, and OC mRNA levels were similar in transduced and control cells. Thus, viral infection did not affect the ability of cells to undergo osteoblastic differentiation (Fig. 7F ).
DISCUSSION
Our data suggest that primary murine osteoprogenitor cells can be efficiently transduced with VSV-G pseudotyped retroviral vectors without affecting their ability to differentiate down the osteoblast lineage.
The basis of gene therapy protocols that use retroviral vectors as tools to deliver a gene of interest is to target a specific cell type. Introduction of exogenous genes has been evaluated in a number of studies using replicationdefective retroviral vectors in secondary cultures of mouse, rat, or human osteoprogenitor cells (Abboud et al., 1998; Onyia et al., 1998; Oyama et al., 1999) . These studies showed a high rate of infection, but used cells that had undergone a significant number of passages. This may increase the potential of these cells to undergo spontaneous transformation, decreased life span, or reduced differentiation ability. In contrast, our study was focused on achieving efficient transduction into primary cell cultures that we believe most closely resemble in vivo osteoblast progenitors.
Mouse marrow stromal cells develop into colonies when cultured in the presence of a hematopoietic "supportive" cell layer and have the ability to progress to osteoblast lineage if cultured under osteoblast-inductive conditions (Friedenstein et al., 1992; Kuznetsov et al., 1997) . As our interest was to target early precursor cells, the presence of hematopoietic feeder cells that outnumber the stromal adherent population and therefore compete for the viral particles in the supernatant presented a problem. Hematopoietic cells were removed and MSC were exposed to viral supernatants. Because after day 4 stromal cells could develop without a supportive microenvironment of hematopoietic cells, we performed the infection starting at this time point. However, by day 4 in culture osteoprogenitor cells had already started to proliferate, resulting in at best an infection rate of 40-50%, along with a distribution that showed the presence of nontransduced or partially infected colonies. In contrast ) represents RNA derived from cells that were not exposed to conditioned media or to protamine sulphate. Filters were hybridized with cDNAs for GFP, LacZ, Col1a1, BSP, and OC. Ethidium bromide staining was used to assess RNA loading.
to stromal cell cultures, calvarial osteoblasts do not require the presence of supportive cells. Therefore, the infection could be performed at earlier time points (after the cells had attached to a plate), resulting in a much higher rate of infection. Increasing the infection rate in primary MSC needs to be addressed by additional experiments. Conditioned media that had been described as supporting stromal cell growth (Lennon et al., 1995) could be used in combination with a higher titer of virus. Furthermore the VSV-G pseudotyped retroviral particles are stable enough to support two rounds of ultracentrifugation that can increase the titer up to 1000-fold (Burns et al., 1993) .
Recent studies have shown that retroviral infection was successful in secondary culture of human marrowderived mesenchymal progenitor cells in expressing factors such as human interleukin-3 (Allay et al., 1997) without affecting the osteogenic ability of transduced cells. Transplantation of human bone marrow cells has been applied in human subjects with osteogenesis imperfecta (Horwitz et al., 1999) , resulting in engraftment of 1-2% of stromal cells with questionable success in primary disease improvement (Bianco and Gehron Robey, 2000) . These protocols require a severe preoperative treatment, and they raise ethical questions. We believe that it is premature and inappropriate to carry out studies testing engraftment of stromal cells on human subjects. This suggests the importance of testing gene therapy procedures based on the use of retroviral vectors in murine models.
Our experiments were designed to achieve efficient transduction of osteoprogenitor cells and to test the osteogenic differentiation ability of both murine marrowderived mesenchymal progenitor cells and calvarial progenitors after transduction with VSV pseudotyped retrovectors. We observed that there were no changes in mineralization and osteocalcin expression as well as the expression of other bone-related genes like BSP, ALP, and type I collagen following the transduction. Furthermore, the mineralized areas contained cells expressing strong transgene signals suggesting that cells infected during the progenitor stage continued to express transgene while attaining their fully differentiated osteoblastic phenotype.
In summary, we have demonstrated the capability of VSV-G pseudotyped retroviruses to transduce murine osteoprogenitor cells without affecting their proliferation and differentiation capabilities. Our data indicate the advantages and reliability of using VSV-G pseudotyped retroviral vectors in future gene therapy studies.
MATERIAL AND METHODS
Production of pseudotyped retroviral vectors
In this study we used retroviral vectors that encode either the marker gene ␤-galactosidase (MFG.S.nlsLZ) or an enchanced version of green fluorescent protein (MG1) (Fig. 1) . Both retroviruses were produced by the human embryonic kidney cell line 293GPG. The GPGnlsLacZ2, a high-titer producer cell line of the MFG.S.nlsLZ vector, was a generous gift from Dr. R. C. Mulligen (Ory et al., 1996) . MG1, an eGFP-encoding retrovector made by introducing a CMV promoter driving eGFP into the pLXSN vector (Miller et al., 1993) , was kindly provided by Dr. D. Dorsky. The MG1 retrovector was transfected into 293GPG cells, followed by expan- sion of the brightest clone to obtain a high-titer producer cell line. The 293GPG packaging cell lines were grown in Dulbecco's modified Eagle medium with 5 g glucose/L (DMEM-high glucose, GIBCO BRL), with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, and 50 U/ml penicillin and streptomycin. Antibiotic selection was maintained in media with 2 g/ml puromycin, 1 g/ml tetracycline, and 0.3 mg/ml G418. A producer cell line for the nlsLZ2 retrovector was additionally supplemented with 100 g/ml of zeocyn. In order to produce retroviral particles, antibiotics were removed and medium was collected and pooled after 24, 48, 72, and 96 h. The samples contained complete viral particles with VSV-G glycoprotein in the envelope. Viral titers were determined using the DF1 fibroblast cell line. Cells were grown in DMEM-high glucose, 5% FBS and 5% fetal calf serum (FCS) supplemented with 7 g/L tryptose phosphate, 100 U/ml penicillin, and 100 g/ml streptomycin. Cultures were passaged into 24-well plates until reaching 30-40% confluence, after which they were incubated overnight with varying dilutions of the viral supernatants containing 8 g/ml of polybrene. Two days after infection, cells were stained for ␤-galactosidase activity when nlsLZ2 vector was used, or fluorescent colonies were counted for the eGFP-encoding vector. The viral titer was calculated from the number of ␤-galactosidase or GFP-expressing colonies with a correction for the dilution factor.
Isolation and cultivation of cells
Preparation of mouse primary marrow stromal cell culture. Femurs and tibiae from 2-month-old CD-1 mice were dissected and cleaned of attached muscle. The epiphyseal growth plate was removed, and the marrow was collected by flushing culture medium (␣MEM containing 100 U/ml penicillin, 100 g/ml streptomycin, and 10% FCS) through the bone with a 25-gauge needle. A single-cell suspension was achieved by 4-5 cycles of aspiration and expulsion through an 18-gauge needle followed by filtration through a 70-m cell strainer (Falcon, Cat. No. 2350) . Approximately 20 ϫ 10 6 cells per well (four wells per mouse) were seeded in six-well tissue culture plates (Falcon, Cat. No. 3046 ). On day 4, media containing nonadherent cells were removed and the infection procedure was initiated (see below). Starting from day 7, media were supplemented with 25 g/ml ascorbic acid, dexamethasone (10 Ϫ8 M), and ␤-glycerophosphate (8 mM) and were changed every two days.
Preparation of mouse primary neonatal calvaria cell cultures. Isolation of calvarial cells was performed by a modification of the method of Wong and Cohn (1975) . Briefly, calvariae from 7-to 9-day-old CD-1 mice were dissected and the sutures were removed. Calvariae were subjected to four sequential 15-min digestions in an enzyme mixture containing 0.05% trypsin (Life Technologies, Inc.) and 0.1% collagenase P (Boehringer Mannheim) at 37°C on a rocking platform. Fractions 2-4 were collected and cooled by the addition of an equal volume of cold DMEM containing 10% FCS, 100 U/ml penicillin, and 100 g/ml streptomycin. The fractions were pooled, centrifuged, resuspended in DMEM containing 10% FCS, and filtered through a 70-m cell strainer (Falcon, Cat. No. 2350) . Cells were plated at a density of 1-1.5 ϫ 10 4 cells/cm 2 in 35-mm six-well plates in DMEM containing 10% FCS. Cells were given fresh DMEM containing 10% FCS (basal medium) 24 h later and fed again with this medium 3 days later. Viral infections were initiated at this time point (see below). At 1 week of culture, the medium was changed to differentiation medium (␣MEM containing 10% FCS, 25 g/ml ascorbic acid, 4 mM ␤-glycerophosphate) and thereafter the medium was changed every 2 days.
Infection of primary cultures
Both calvarial and marrow stromal cells were infected three times during the period of high proliferation in the presence of 8 g/ml protamine sulphate. On days 4, 5, and 6, MSC were washed in PBS once and exposed to 2 ml of virus for 6 h, whereas calvarial cells were infected on days 2, 3, and 4 of culture using the same protocol. Uninfected cells that were exposed to 8 g/ml protamine sulphate in media collected from 293GPG producer cells that did not contain any retrovector were used as a control (mock). Although it is possible to select the cells by the addition of G418 to the medium, we did not employ this option in the present study.
Flow cytometry analysis was carried out on a FACScan/Calibur (Becton-Dickinson) using a 488-nm excitation wavelength generated by a 15-MW argon ion laser. Emission was detected using a 500-LP (GFP) filter in FL1. Nontransduced calvarial or marrow stromal cells were used as a control.
Fluorescent images of mineralized nodules were obtained using an Olympus IX50 inverted system microscope equipped with an IX-FLA inverted reflected light fluorescence. A specific excitation wavelength was obtained using an additional filter with excitation at 488 nm. In addition, images were taken under regular light microscopy as a grayscale image.
Staining for ␤-galactosidase was performed on cultures that were washed once in 0.1 M phosphate buffer, pH 7.3, fixed for 5 min in 0.8% glutaraldehyde, 5 mM EGTA, and 2 mM Mgcl 2 , and washed three times with washing buffer (0.02% Nonidet P-40, 0.1% deoxycholate in 0.1 M sodium phosphate). Cells were stained overnight at 37°C in a 1 mg/ml concentration of X-gal (Bethesda Research Laboratories) and potassium ferrocyanide (Sigma P-9387, P8131). The infection rate was based on an estimate of the number of cells with blue nuclei compared to the number of negative cells in several visual fields.
Histochemical analysis
Alkaline phosphatase staining was performed according to the manufacturer's instructions (Sigma kit No. 86-R). During the incubation period, cells were protected from direct light exposure and drying. Subsequently, plates were washed twice in deionized water and air dried.
Mineralization was assessed by the von Kossa method. Briefly, cells were fixed for 10 min in 2% paraformaldehyde in 0.1 M cacodylic buffer, pretreated for 20 min with a saturated lithium carbonate solution, and washed with deionized water. The plates were incubated with 5% silver nitrate solution for 30 min under a bright light, washed with water, and treated with a 5% sodium thiosulfate solution for 2-3 min, followed by washing with water and air drying. The results of the staining procedures were recorded with a Kodak DCS420 color digital camera.
RNA extraction and Northern blot analysis
Total RNA was isolated using TRIzol reagent (GIBCO BRL) according to the manufacturer's instructions. The RNA precipitate was washed once with 80% ethanol and redisolved in 50 l of DEPC water. RNA was separated on a 2.2 M formaldehyde 1% agarose gel and transferred onto a nylon membrane (Maximum Strength Nytran, Schleicher & Schuell). Membranes were probed with eGFP, ␤-gal cDNA, rat Col1A1 (p␣1R2) (Genovese et al., 1984) , mouse OC (Celeste et al., 1986) , and mouse bone sialoprotein (Young et al., 1994) cDNAs. Probes were radiolabeled using the random primer method using [␣- 32 P]dCTP (New England Nuclear, 3000 Ci/mM). Filters were hybridized with 3 ϫ 10 6 cpm/ml at 42°C in 50% formamide, 5ϫ SSPE (1ϫ SSPE is 0.149 M NaCl, 10 mM NaH 2 PO 4 , 1 mM EDTA, pH 7.4), 1.2ϫ Denhardt's, 0.5% sodium dodecyl sulfate (Sambrook et al., 1989) . Filters were washed with 6ϫ SSPE and 0.5% SDS for 10 min at room temperature, 0.1ϫ SSPE and 0.1% SDS for 10 min at 37°C, and once in 0.1ϫ SSPE and 0.1% SDS for 10 min at 65°C. Prior hybridization signals were removed by washing in 0.1ϫ SSPE and 0.1% SDS for 20-30 min at 80°C.
